is berberine a glp 1 booster GLP-1 Agonist? Evidence and Mechanism Explained ColonBroom GLP-1 Weight Management for

Wegovy (semaglutide) and Zepbound (tirzepatide) are both FDA-approved for weight management in adults with obesity or overweight with a weight-related health condition, regardless of whether diabetes is present

Demand soared after the FDA approved Wegovy and Zepbound for weight loss in 2021 and 2023, respectively

If you are considering whether to stop semaglutide abruptly versus tapering, that decision should be medical, not based on running out of medication

For example, people dont stop taking blood pressure medication once they reach their target numbers

Constipation affects 1015% of GLP-1 users

Weight loss continues at the lower dose, albeit at a slower rate, and the metabolic health improvements accumulated during the higher-dose phase persist as long as the protocol continues